ChromaDex shareholders elect all 8 director nominees, ratify auditor, and approve say-on-pay at 2024 annual meeting

Niagen Bioscience, Inc.

All eight director nominees elected: Jaksch, Fried, Rubin, Yu, Ng, Patrick, Cohen, Shahbazi.
Ratification of Marcum LLP as FY 2024 auditor passed with 49.6M for, 3.4M against, 83,650 abstain.
Advisory approval of named executive officer compensation passed with 40.8M for, 0.9M against, 0.5M abstain.
Broker non-votes of 10.9M reported for director election and say-on-pay proposals.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.